Irritable Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Colonoscopic Probiotics Infusion for Functional Gastrointestinal Disease [Phase 4]
Phase 4 trial update on colonoscopic probiotic infusion for functional gastrointestinal diseases, including functional constipation and irri…
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Self Administered Cognitive Behavior Therapy for Irritable Bowel Syndrome [NA]
A completed clinical trial investigating self-administered cognitive behavioral therapy for Irritable Bowel Syndrome; results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Efficacy and Safety of IBS Digital Behavioral Treatment [NA]
Completed clinical trial evaluating the efficacy and safety of a digital behavioral treatment for irritable bowel syndrome.
-
CLINICAL_TRIALS trial_result · 2022-03-14Clinical Trial Update: Dose Escalation Trial of Traditional Chinese Medicine for Irritable Bowel Syndrome (TCM- IBS) [Phase 2]
Phase 2 dose-escalation trial of traditional Chinese medicine for irritable bowel syndrome has been completed.
-
CLINICAL_TRIALS trial_result · 2022-01-24Clinical Trial Update: Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study [Phase 2]
A Phase 2 pharmacokinetic study comparing a 182 mg colon-targeted peppermint oil capsule with an enteric-coated peppermint oil capsule in ir…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: A Trial for New Treatment of Adult Participants With Irritable Bowel Syndrome [Phase 2]
Phase 2 clinical trial update for a new treatment in adults with Irritable Bowel Syndrome has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2021-12-30Clinical Trial Update: Gut Microbiota Reconstruction in the Treatment of Irritable Bowel Syndrome With Predominant Diarrhea [Phase 2, Phase 3]
A clinical trial update on gut microbiota reconstruction for irritable bowel syndrome with predominant diarrhea, spanning Phase 2 and Phase …
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Exploratory Study on Dosage of Qizhi Weitong Granules in the Treatment of Irritable Bowel Syndrome （IBS) [Phase 2]
Phase 2 exploratory study evaluating dosage of Qizhi Weitong Granules for Irritable Bowel Syndrome.
-
FDA approval · 2021-10-25FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved Amneal Pharmaceuticals NY LLC's original application for a generic Librax (chlordiazepoxide hydrochloride and clidinium bromide…
-
CLINICAL_TRIALS trial_result · 2021-10-22Clinical Trial Update: The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome [Phase 2, Phase 3]
Phase 2/3 clinical trial investigating prucalopride for constipation-predominant irritable bowel syndrome (IBS-C).
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Pain Relief In Irritable Bowel Syndrome [Phase 4]
Phase 4 trial update for a pain relief treatment in Irritable Bowel Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Fecal Microbiota Transplantation for Irritable Bowel Syndrome [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial update on fecal microbiota transplantation for irritable bowel syndrome ongoing recruitment.
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome [Phase 2]
Phase 2 trial evaluating oral vibegron for 12 weeks in women with irritable bowel syndrome has completed with results posted.
-
CLINICAL_TRIALS research · 2021-07-23Clinical Trial Update: Efficacy of Open Label Placebo in Children With FGIDs [NA]
Clinical trial update on the efficacy of open-label placebo in children with functional gastrointestinal disorders, including functional abd…
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Does Improving Vagal Tone Increase Mitochondrial Bioenergetics [NA]
Completed clinical trial investigating whether improving vagal tone can enhance mitochondrial bioenergetics in functional GI disorders and i…
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]
Phase 2 clinical trial evaluating BOS-589 for diarrhea-predominant irritable bowel syndrome has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Management of Irritable Bowel Syndrome in Primary Care (MIBS Trial) [Phase 4]
Phase 4 clinical trial update on managing Irritable Bowel Syndrome in primary care.
-
FDA approval · 2021-04-23FDA Approved: DICYCLOMINE HYDROCHLORIDE — Original Application (Novitium Pharma LLC)
The FDA approved Novitium Pharma LLC's original ANDA for dicyclomine hydrochloride, enabling a generic version to enter the market.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: The Effect of Citrus Extract on Gastrointestinal Health [Phase 2]
Phase 2 clinical trial investigating citrus extract for irritable bowel syndrome has completed.
-
FDA approval · 2021-02-05FDA Approved: LIBRAX — Supplemental Application (Bausch Health US, LLC)
FDA approved a supplemental application for Librax (chlordiazepoxide hydrochloride and clidinium bromide) from Bausch Health US, LLC.
-
CLINICAL_TRIALS trial_result · 2020-12-31Clinical Trial Update: The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study [Phase 3]
Phase 3 pilot trial investigating long-acting mesalamine for post-infective irritable bowel syndrome; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome [NA]
A completed trial assessing acceptability and efficacy of the Zemedy app for Irritable Bowel Syndrome with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: The DOMINO Trial: Diet Or Medication in Irritable Bowel syNdrOme [Phase 4]
Phase 4 clinical trial update for the DOMINO study investigating diet versus medication in Irritable Bowel Syndrome.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial Overgrowth [Phase 4]
Phase 4 trial assessing efficacy and safety of Saccharomyces boulardii for irritable bowel syndrome.
-
FDA approval · 2020-10-20FDA Approved: CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE — Original Application (Chartwell RX, LLC)
FDA approves the fixed-dose combination of chlordiazepoxide hydrochloride and clidinium bromide under an original application for Chartwell …